These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 34503099)
1. Combination of Pembrolizumab with Electrochemotherapy in Cutaneous Metastases from Melanoma: A Comparative Retrospective Study from the InspECT and Slovenian Cancer Registry. Campana LG; Peric B; Mascherini M; Spina R; Kunte C; Kis E; Rozsa P; Quaglino P; Jones RP; Clover AJP; Curatolo P; Giorgione R; Cemazar M; Terlizzi F; Bosnjak M; Sersa G Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503099 [TBL] [Abstract][Full Text] [Related]
2. Electrochemotherapy for advanced cutaneous angiosarcoma: A European register-based cohort study from the International Network for Sharing Practices of electrochemotherapy (InspECT). Campana LG; Kis E; Bottyán K; Orlando A; de Terlizzi F; Mitsala G; Careri R; Curatolo P; Snoj M; Sersa G; Valpione S; Quaglino P; Mowatt D; Brizio M; Schepler H Int J Surg; 2019 Dec; 72():34-42. PubMed ID: 31618680 [TBL] [Abstract][Full Text] [Related]
3. Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. Rotunno R; Campana LG; Quaglino P; de Terlizzi F; Kunte C; Odili J; Gehl J; Ribero S; Liew SH; Marconato R; Brizio M; Curatolo P J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1147-1154. PubMed ID: 29178483 [TBL] [Abstract][Full Text] [Related]
4. Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Kunte C; Letulé V; Gehl J; Dahlstroem K; Curatolo P; Rotunno R; Muir T; Occhini A; Bertino G; Powell B; Saxinger W; Lechner G; Liew SH; Pritchard-Jones R; Rutkowski P; Zdzienicki M; Mowatt D; Sykes AJ; Orlando A; Mitsala G; Rossi CR; Campana L; Brizio M; de Terlizzi F; Quaglino P; Odili J; Br J Dermatol; 2017 Jun; 176(6):1475-1485. PubMed ID: 28118487 [TBL] [Abstract][Full Text] [Related]
14. Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases. Ricotti F; Giuliodori K; Cataldi I; Campanati A; Ganzetti G; Ricotti G; Offidani A Dermatol Ther; 2014; 27(3):148-52. PubMed ID: 24903471 [TBL] [Abstract][Full Text] [Related]
15. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma. Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201 [TBL] [Abstract][Full Text] [Related]
16. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Quaglino P; Mortera C; Osella-Abate S; Barberis M; Illengo M; Rissone M; Savoia P; Bernengo MG Ann Surg Oncol; 2008 Aug; 15(8):2215-22. PubMed ID: 18498012 [TBL] [Abstract][Full Text] [Related]
17. The use of electrochemotherapy in combination with immunotherapy in the treatment of metastatic melanoma: a focused review. Goggins CA; Khachemoune A Int J Dermatol; 2019 Aug; 58(8):865-870. PubMed ID: 30479009 [TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab - real-world experience. Hribernik N; Boc M; Ocvirk J; Knez-Arbeiter J; Mesti T; Ignjatovic M; Rebersek M Radiol Oncol; 2020 Jan; 54(1):119-127. PubMed ID: 31955148 [TBL] [Abstract][Full Text] [Related]
19. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Campana LG; Valpione S; Falci C; Mocellin S; Basso M; Corti L; Balestrieri N; Marchet A; Rossi CR Breast Cancer Res Treat; 2012 Aug; 134(3):1169-78. PubMed ID: 22821399 [TBL] [Abstract][Full Text] [Related]
20. Potential dual synergy between electrochemotherapy and sequence of immunotherapies in metastatic melanoma: A case report. Morgese F; De Feudis F; Balercia P; Berardi R Mol Clin Oncol; 2023 Feb; 18(2):8. PubMed ID: 36761389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]